Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,355Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6FRESENIUS KABI USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7857802

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-28

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 8162915

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-23

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 8162915

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-23

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7828787

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-18

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7828787

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-18

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7857802

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-28

blank